Clinical Trial: Assess the Efficacy and Safety of Repeat Intravitreal Injections of Foselutoclax (UBX1325) in Patients With DME (ASPIRE)
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Diabetic Macular Edema
Study Type: INTERVENTIONAL
Official Title: A Phase 2b, Prospective, Multicenter, Randomized, Double-Masked, Active-Controlled Study to Assess the Efficacy and Safety of Repeat Intravitreal Injections of Foselutoclax (UBX1325) in Patients With
Brief Summary:
The goal of this clinical trial is to assess the efficacy and safety of multiple doses of foselutoclax (UBX1325) in patients with Diabetic Macular Edema.The main questions the study aims to answer are:Assess the efficacy of foselutoclax compared to afliberceptAssess the safety and tolerability of foselutoclax
Read more